SG Americas Securities’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
CCC
ACM
OIA
AIC
KCM
SG Americas Securities's ABEO Position: Q2 2026 in Review
SG Americas Securities opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 13,015 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #3156 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in ABEO as recently as Q4 2025.
SG Americas Securities first reported a position in ABEO in Q1 2016 and has held it in 14 quarters since. The position peaked at $235K in Q3 2018. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.
- SG Americas Securities held 13,015 shares of Abeona Therapeutics worth $80K as of Q2 2026.
- Abeona Therapeutics was a new SG Americas Securities position in Q2 2026.
- Abeona Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3156 holding.
- SG Americas Securities first reported a position in Abeona Therapeutics in Q1 2016 and has held it in 14 quarters since.
- SG Americas Securities's Abeona Therapeutics position peaked at $235K in Q3 2018.
- 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.